Atara Biotherapeutics Statistics
Total Valuation
ATRA has a market cap or net worth of $79.02 million. The enterprise value is $80.75 million.
| Market Cap | 79.02M |
| Enterprise Value | 80.75M |
Important Dates
The next estimated earnings date is Tuesday, August 11, 2026, after market close.
| Earnings Date | Aug 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ATRA has 9.01 million shares outstanding. The number of shares has increased by 52.43% in one year.
| Current Share Class | 9.01M |
| Shares Outstanding | 9.01M |
| Shares Change (YoY) | +52.43% |
| Shares Change (QoQ) | +3.38% |
| Owned by Insiders (%) | 2.86% |
| Owned by Institutions (%) | 26.33% |
| Float | 4.02M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.41 |
| Forward PS | 51.53 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.49 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.16
| Current Ratio | 2.16 |
| Quick Ratio | 1.48 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.75 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -3.83% |
| Return on Invested Capital (ROIC) | -25.56% |
| Return on Capital Employed (ROCE) | -43.96% |
| Weighted Average Cost of Capital (WACC) | 7.46% |
| Revenue Per Employee | $1.78M |
| Profits Per Employee | -$728,231 |
| Employee Count | 13 |
| Asset Turnover | 0.56 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ATRA has paid $31,000 in taxes.
| Income Tax | 31,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -24.07% in the last 52 weeks. The beta is 0.10, so ATRA's price volatility has been lower than the market average.
| Beta (5Y) | 0.10 |
| 52-Week Price Change | -24.07% |
| 50-Day Moving Average | 9.63 |
| 200-Day Moving Average | 9.36 |
| Relative Strength Index (RSI) | 49.44 |
| Average Volume (20 Days) | 76,452 |
Short Selling Information
The latest short interest is 577,635, so 6.41% of the outstanding shares have been sold short.
| Short Interest | 577,635 |
| Short Previous Month | 361,520 |
| Short % of Shares Out | 6.41% |
| Short % of Float | 14.38% |
| Short Ratio (days to cover) | 6.26 |
Income Statement
In the last 12 months, ATRA had revenue of $23.14 million and -$9.47 million in losses. Loss per share was -$0.71.
| Revenue | 23.14M |
| Gross Profit | 16.22M |
| Operating Income | -2.51M |
| Pretax Income | -9.44M |
| Net Income | -9.47M |
| EBITDA | -5.96M |
| EBIT | -6.31M |
| Loss Per Share | -$0.71 |
Balance Sheet
The company has $8.36 million in cash and $10.09 million in debt, with a net cash position of -$1.73 million or -$0.19 per share.
| Cash & Cash Equivalents | 8.36M |
| Total Debt | 10.09M |
| Net Cash | -1.73M |
| Net Cash Per Share | -$0.19 |
| Equity (Book Value) | -37.31M |
| Book Value Per Share | -4.38 |
| Working Capital | 6.53M |
Cash Flow
| Operating Cash Flow | -25.88M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 350,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -25.88M |
| FCF Per Share | -$2.87 |
Margins
Gross margin is 70.11%, with operating and profit margins of -10.86% and -40.91%.
| Gross Margin | 70.11% |
| Operating Margin | -10.86% |
| Pretax Margin | -40.78% |
| Profit Margin | -40.91% |
| EBITDA Margin | -25.75% |
| EBIT Margin | -27.27% |
| FCF Margin | n/a |
Dividends & Yields
ATRA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -52.43% |
| Shareholder Yield | -52.43% |
| Earnings Yield | -11.98% |
| FCF Yield | -32.75% |
Analyst Forecast
The average price target for ATRA is $13.67, which is 55.87% higher than the current price. The consensus rating is "Buy".
| Price Target | $13.67 |
| Price Target Difference | 55.87% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | -32.10% |
| EPS Growth Forecast (3Y) | -32.61% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 20, 2024. It was a reverse split with a ratio of 1:25.
| Last Split Date | Jun 20, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:25 |
Scores
ATRA has an Altman Z-Score of -139.98 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -139.98 |
| Piotroski F-Score | 2 |